Key facts
- Notable investors include Beijing State-owned Capital Operation and Management, Shun Xi Fund, Zhongguancun Development Venture Capital Fund, Lotus Lake Ventures, Ruisheng Equity — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Ace Cardio
- ·The full record, as it builds
Funding rounds
No funding rounds for Ace Cardio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Ace Cardio
Manufacturer of interventional cardiovascular devices designed for minimally invasive procedures in cardiology, neurology, and peripheral vascular interventions. The company focuses on the core of new interventional ultrasound technology and develops and produces a series of products, such as interventional ultrasound imagers, providing doctors with reliable tools for accurate diagnosis and treatment, thereby improving the quality of medical care and ultimately benefiting patients and improving the quality of life.
- Sector
- Healthcare
- HQ
- Beijing, China
- Founded
- 2022
- Website
- ace-cardio.com/
- Ownership
- Privately Held (backing)
Ace Cardio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ace Cardio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ace Cardio in its N-PORT filings yet. We sweep new filings monthly.